Cognex director exercises 2,913 restricted stock units

Cognex Corporation director Marjorie Sennett reported the exercise and conversion of 2,913 restricted stock units into an equal number of Cognex common shares at a price of $0.00 per share.

Rhea-AI Filing Summary

Cognex Corporation director Marjorie Sennett reported the exercise and conversion of 2,913 restricted stock units into an equal number of Cognex common shares at a price of $0.00 per share. After this transaction, she directly holds 25,936 common shares and 4,817 restricted stock units.

The restricted stock units each represent a contingent right to receive one share of common stock and vest in stages of approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the February 21, 2023 grant date.

Insider Trade Summary

2,913 shares exercised/converted

Exercise 3 txns

Insider Sennett Marjorie

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	2,913	$0.00	$0.00
Exercise	Common Stock	2,913	$0.00	$0.00
holding	Restricted Stock Unit	--	--	--

Holdings After Transaction: Restricted Stock Unit — 4,817 contracts (Direct); Common Stock — 25,936 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
2. F2. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Cognex (CGNX) director Marjorie Sennett report?

Cognex director Marjorie Sennett reported exercising 2,913 restricted stock units into 2,913 shares of common stock at $0.00 per share. This was an exercise or conversion of derivative securities, not an open-market stock purchase or sale.

How many Cognex (CGNX) shares does Marjorie Sennett own after this Form 4?

Following the reported transactions, Marjorie Sennett directly owns 25,936 shares of Cognex common stock. She also holds 4,817 restricted stock units, which represent additional potential shares subject to vesting conditions tied to the original grant date.

What happened to the restricted stock units in the Cognex (CGNX) Form 4 filing?

In the filing, 2,913 restricted stock units were exercised and converted into 2,913 Cognex common shares. Restricted stock units are derivative awards that turn into common stock once vesting and any other conditions are satisfied, as reflected in this transaction.

What is the vesting schedule for Cognex (CGNX) director Marjorie Sennett’s restricted stock units?

Her restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the February 21, 2023 grant date. Each unit represents a contingent right to receive one share of Cognex common stock upon vesting.

Were there any Cognex (CGNX) insider share sales reported in this Form 4?

The Form 4 reflects exercises and conversions of restricted stock units into common shares by director Marjorie Sennett, not open-market sales. Reported transactions increased her directly held common shares to 25,936, along with 4,817 remaining restricted stock units after the activity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:50 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sennett Marjorie

(Last) (First) (Middle)

1 VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/21/2026		M		2,913	A	$0.0	25,936	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.0(1)	02/21/2026		M			2,913	02/21/2024(2)	02/21/2026	Common Stock	2,913	$0.0	0	D
Restricted Stock Unit	$0.0							02/17/2027	02/17/2027	Common Stock	4,817		4,817	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

2. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.

	Marjorie Sennett	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.